General Information of the Compound
Compound ID
CP0341725
Compound Name
1-{4-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}-3-(2-hydroxyethyl)urea
    Show/Hide
Structure
Formula
C30H36N8O3
Molecular Weight
556.671
Canonical SMILES
OCCNC(=O)Nc1ccc(cc1)-c1nc(N2CCOCC2)c2cnn(C3CCN(Cc4ccccc4)CC3)c2n1
    Show/Hide
InChI
InChI=1S/C30H36N8O3/c39-17-12-31-30(40)33-24-8-6-23(7-9-24)27-34-28(37-15-18-41-19-16-37)26-20-32-38(29(26)35-27)25-10-13-36(14-11-25)21-22-4-2-1-3-5-22/h1-9,20,25,39H,10-19,21H2,(H2,31,33,40)
    Show/Hide
InChIKey
ZZCOJCXQAHQFAH-UHFFFAOYSA-N
Physicochemical Property
logP
3.2808
Rotatable Bonds
8
Heavy Atom Count
41
Polar Areas
120.67
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
9
Complexity
41

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 25195788
SID: 57305357
ChEMBL ID
CHEMBL1097896
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 0.3 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000141 LNCaP Homo sapiens (Human)  1
1
IC50 = 26 nM
   TI
   LI
   LO
   TS